---
$id: https://graph.org.ai/products/commodity/51372001
$type: Product
source: UNSPSC
code: "51372001"
title: "Desomorphine"
class: "51372000"
classTitle: "Controlled substance analgesic morphinans"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Desomorphine

**UNSPSC Code**: 51372001
**Class**: [Controlled substance analgesic morphinans](Controlled substance analgesic morphinans.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist with the molecular formula C17H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7OP86J5E33, chemically known as morphinan-3-ol, 4,5-epoxy-17-methyl-, (5.alpha.)- but generally known as desomorphine, which bears US NIH Compound Identifier 521115. European Medicines Agency schedules Desomorphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07004MIG. The term DESOMORPHINE is an International Non-Proprietary Name. DESOMORPHINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule desomorphine under HS 29391900 and SITC 54141. As of Q4 2014, DESOMORPHINE remains the US FDA Preferred Term for this commodity. Desomorphine bears US NLM identifiers UMLS ID C2827133 and NCI Concept Code C83663. SMILES: O1C2C34C(C(N(CC3)C)CC3C4C1C(O)CC3)CCC2.

